BR9910677A - Processo de preparação de ésteres de<244>-fenilalanina substancialmenteenantiomericamente puros e utilização de umaenzima total ou parcialmente purificada de tipoprotease - Google Patents

Processo de preparação de ésteres de<244>-fenilalanina substancialmenteenantiomericamente puros e utilização de umaenzima total ou parcialmente purificada de tipoprotease

Info

Publication number
BR9910677A
BR9910677A BR9910677-9A BR9910677A BR9910677A BR 9910677 A BR9910677 A BR 9910677A BR 9910677 A BR9910677 A BR 9910677A BR 9910677 A BR9910677 A BR 9910677A
Authority
BR
Brazil
Prior art keywords
preparation
partially purified
enantiomerically pure
fully
substantially enantiomerically
Prior art date
Application number
BR9910677-9A
Other languages
English (en)
Inventor
Marie-Claude Bontoux
Olivier Favre-Bulle
Original Assignee
Aventis Cropscience Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Cropscience Sa filed Critical Aventis Cropscience Sa
Publication of BR9910677A publication Critical patent/BR9910677A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/005—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/80—Two oxygen atoms, e.g. hydantoin with hetero atoms or acyl radicals directly attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/04—Alpha- or beta- amino acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)

Abstract

"PROCESSO DE PREPARAçãO DE éSTERES DE<244>-FENILALANINA SUBSTANCIALMENTEENANTIOMERICAMENTE PUROS E UTILIZAçãO DE UMAENZIMA TOTAL OU PARCIALMENTE PURIFICADA DE TIPOPROTEASE". Processo de preparação de ésteres de<244>-fenilalanina substancialmente enatiomericamente puros defórmula (1) e (II) nas quais Alk representa um radical alquila linearou ramificado que comporta de 1 a 6 átomos de carbono,caracterizado pelo fato de colocarmos em presença uma misturade enanciómeros de ésteres da <244>-fenilalanina com uma lipase,uma protease, ou uma estearase.
BR9910677-9A 1998-05-14 1999-05-10 Processo de preparação de ésteres de<244>-fenilalanina substancialmenteenantiomericamente puros e utilização de umaenzima total ou parcialmente purificada de tipoprotease BR9910677A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9806339A FR2778671B1 (fr) 1998-05-14 1998-05-14 Nouveau procede de preparation d'intermediaires de synthese
PCT/FR1999/001098 WO1999058706A1 (fr) 1998-05-14 1999-05-10 Nouveau procede de preparation d'intermediaires de synthese

Publications (1)

Publication Number Publication Date
BR9910677A true BR9910677A (pt) 2001-11-20

Family

ID=9526525

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9910677-9A BR9910677A (pt) 1998-05-14 1999-05-10 Processo de preparação de ésteres de<244>-fenilalanina substancialmenteenantiomericamente puros e utilização de umaenzima total ou parcialmente purificada de tipoprotease

Country Status (17)

Country Link
US (1) US6551816B1 (pt)
EP (1) EP1076718B1 (pt)
JP (1) JP4553485B2 (pt)
KR (1) KR100576276B1 (pt)
CN (1) CN1196795C (pt)
AT (1) ATE217025T1 (pt)
AU (1) AU3610299A (pt)
BR (1) BR9910677A (pt)
CA (1) CA2337269C (pt)
DE (1) DE69901388T2 (pt)
DK (1) DK1076718T3 (pt)
ES (1) ES2175966T3 (pt)
FR (1) FR2778671B1 (pt)
HU (1) HU228080B1 (pt)
IL (1) IL139600A0 (pt)
PT (1) PT1076718E (pt)
WO (1) WO1999058706A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6759551B1 (en) 2000-11-03 2004-07-06 Bayer Cropscience S.A. Chiral (s- or r-methylphenylglycine) amino acid crystal and method for preparing same
US7794965B2 (en) 2002-03-13 2010-09-14 Signum Biosciences, Inc. Method of identifying modulators of PP2A methylase
US7923041B2 (en) 2005-02-03 2011-04-12 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
WO2006084033A1 (en) * 2005-02-03 2006-08-10 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
JP2008260755A (ja) * 2007-03-20 2008-10-30 Sumitomo Chemical Co Ltd Ｌ−ビフェニルアラニン化合物の塩の回収方法、およびそれを用いたビフェニルアラニンエステル化合物の回収方法
EP2282735B1 (en) 2008-04-21 2019-01-16 Signum Biosciences, Inc. Pp2a modulators for treating alzheimer, parkinson, diabetes
CN101555211B (zh) * 2009-05-13 2012-01-25 浙江九洲药业股份有限公司 2-酰基氨基-3-联苯基丙酸的化学合成方法
CN102321690B (zh) * 2011-07-27 2012-07-18 陆宏国 一种酯类手性胺化合物的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3438189A1 (de) * 1984-10-18 1986-04-24 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung aromatisch substituierter l-aminosaeuren
FR2706456B1 (fr) 1993-06-18 1996-06-28 Rhone Poulenc Agrochimie Dérivés optiquement actifs de 2-imidazoline-5-ones et 2-imidazoline-5-thiones fongicides.
US5552317A (en) * 1995-05-26 1996-09-03 Industrial Technology Research Institute Method for preparing optically active homophenylalanine and esters thereof using lipase from wheat germ or Candida lipolytica
US5552318A (en) * 1995-05-26 1996-09-03 Industrial Technology Research Institute Method for preparing optically active amino acids and their esters using wheat germ lipase
FR2751327A1 (fr) * 1996-07-22 1998-01-23 Rhone Poulenc Agrochimie Intermediaires pour la preparation de 2-imidazoline-5-ones

Also Published As

Publication number Publication date
KR20010025022A (ko) 2001-03-26
WO1999058706A1 (fr) 1999-11-18
CA2337269A1 (fr) 1999-11-18
DK1076718T3 (da) 2002-08-12
CN1348500A (zh) 2002-05-08
DE69901388T2 (de) 2002-08-29
AU3610299A (en) 1999-11-29
KR100576276B1 (ko) 2006-05-04
ES2175966T3 (es) 2002-11-16
HUP0102348A2 (hu) 2001-10-28
FR2778671A1 (fr) 1999-11-19
FR2778671B1 (fr) 2002-07-05
DE69901388D1 (de) 2002-06-06
JP2002514436A (ja) 2002-05-21
US6551816B1 (en) 2003-04-22
CA2337269C (fr) 2007-04-10
JP4553485B2 (ja) 2010-09-29
EP1076718A1 (fr) 2001-02-21
CN1196795C (zh) 2005-04-13
PT1076718E (pt) 2002-09-30
HU228080B1 (en) 2012-10-29
ATE217025T1 (de) 2002-05-15
IL139600A0 (en) 2002-02-10
HUP0102348A3 (en) 2006-03-28
EP1076718B1 (fr) 2002-05-02

Similar Documents

Publication Publication Date Title
AU2001283355A1 (en) Compositions containing hypotriglyceridemically active stilbenoids
AU657166B2 (en) Novel 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
GR3026222T3 (en) Novel mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
AU2524692A (en) Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace
BR9813022A (pt) Derivados de ésteres hidroxiacéticos, seu processo de preparação e sua utilização como intermediários de sìntese
AU2865089A (en) Organopolysiloxane compositions which can be crosslinked to form elastomers with elimination of alcohols
FI943728A0 (fi) Enkefalinaasin ja ACE:n inhibiittoreina käyttökelpoisia uusia aminoasetyylimerkaptojohdannaisia
ATE293967T1 (de) Zusammensetzungen enthaltend stilbenoide mit einer hypoglykämischen wirkung
ES2164060T3 (es) Concentrado de enzima purificada y metodo de preparacion.
MY116928A (en) Purification of crude acrylic acid by crystallization
ATE60763T1 (de) Pyrrolidinylamidesterderivate mit antiprolylendopeptidaseaktivitaet, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische zubereitungen.
CA1274537C (en) PENTAERYTHRITOL-TYPE COESTERS
BR9910677A (pt) Processo de preparação de ésteres de&lt;244&gt;-fenilalanina substancialmenteenantiomericamente puros e utilização de umaenzima total ou parcialmente purificada de tipoprotease
SE8404930L (sv) Vattenhaltiga kompositioner, som innehaller stabiliserade enzymer
AU8062487A (en) New substituted cephalosporin sulfones as anti-inflammatory and antidegenerative agents
BR9915223A (pt) Processo para a preparação contìnua de ésteres alquìlicos de ácido (met) acrìlico
DK0783473T3 (da) Fremgangsmåde til oprensning af 2,6-diisopropylphenol
ES2147196T3 (es) Procedimiento para la hidrolisis estereoespecifica de derivados de piperidindiona.
DK165364C (da) Fedtsyreestere, kosmetisk middel indeholdende disse og fremgangsmaade til fremstilling af saadanne estere
ES2054480T3 (es) Nuevos sustratos de enzimas, analogos de acidos grasos.
DK0415902T3 (da) Oxy- eller thiosubstituerede fedtsyreanaloger til anvendelse ved behandling af retrovirale infektioner
DE59808546D1 (de) Verwendung von fettsäureniedrigalkylestern in abbeizmitteln
MX9603348A (es) Derivados de disulfuro de amida indano-2-mercaptoacetilica novedosos utiles como inhibidores de encefalinasa.
ES2196783T3 (es) Nuevo procedimiento de preparacion de la fexofenadina.
PT82547B (pt) Processo de preparacao de acidos hexenoicos e de composicoes farmaceuticas que os contem

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B25D Requested change of name of applicant approved

Owner name: BAYER CROPSCIENCE S.A. (FR)

Free format text: NOME ALTERADO DE: AVENTIS CROPSCIENCE S.A.

B25G Requested change of headquarter approved

Owner name: BAYER CROPSCIENCE S.A. (FR)

Free format text: ENDERECO ALTERADO CONFORME SOLICITADO NA PETICAO NO 018100045262/SP DE 29/11/2010.

B25A Requested transfer of rights approved

Owner name: BAYER SAS (FR)

Free format text: TRANSFERIDO POR FUSAO DE: BAYER CROPSCIENCE S.A.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O C/C 11 E 13 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]